Berkshire Hathaway Divests Shares of UnitedHealth - Market Insights 2025

Berkshire Hathaway has divested over 5 million shares of UnitedHealth Group shortly after acquiring a stake in the company, as revealed in a regulatory filing dated May 15. Originally, in August, Berkshire announced the purchase of these shares during the second quarter of 2025 for approximately $1.6 billion. The transaction occurred amidst a period of significant challenges for UnitedHealth, including federal scrutiny regarding its Medicare Advantage division, leadership changes, and the aftermath of former CEO Brian Thompson's passing in December 2024.

Following the recent announcement on May 18, UnitedHealth’s stock dipped by nearly 2%. Berkshire's investment came as UnitedHealth endeavored to restore investor confidence after a tumultuous period last year. In May 2025, with Stephen Hemsley’s return as CEO, he assured investors that the provider was rectifying "pricing and operational mistakes" and instilling a "tone of change and reform."

Since then, UnitedHealth has demonstrated resilience, posting a profit of $6.28 billion for the first quarter of 2026. Additionally, the company revised its adjusted earnings per share forecast for the year to exceed $18.25. As of May 18, the company's shares closed at $391, still below the November 2024 peak of $603. The reasons for Berkshire’s decision to sell the shares remain undisclosed.